«Major Histocompatibility Complex

Below is an extended Major Histocompatibility Complex patents listing. Click here to return to the Major Histocompatibility Complex main in depth entry.

Patents :
US Patent No.	Title
7402307	Method for identifying and killing cancer cells
7405076	Generation and use of dendritic cells
7405273	Chimeric immunogens
7405286	Stars--A muscle-specific actin-binding protein
7405290	Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
7407511	Methods and materials for connective tissue repair
7407658	Vaccines for blocking transmission of plasmodium vivax
7407661	Methods and reagents that generate a CD8 T cell immune response
7407936	Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy
7407978	Heterocyclic analogs of diphenylethylene compounds
7408029	Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
7405060	Gene amplification methods
7404963	Flagellin-based adjuvants and vaccines
7404956	Immunoglobulin chimeric monomer-dimer hybrids
7402314	In vivo activation of tumor-specific cytotoxic T cells
7402319	Cell-free tissue replacement for tissue engineering
7402322	Methods of treatment for septic shock with urine extract
7402393	Methods of screening for antagonists of APM1/GZIP
7402417	P450 oxygenases and methods of use
7402430	MHC class II antigen-presenting systems and methods for activating CD4.sup.+ T cells
7402432	Process for producing T lymphocytes
7402735	Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
7404270	Tumor antigen
7404950	Induced activation in dendritic cell
7408031	Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
7408037	Tumor antigen
7413894	TAG-1 and TAG-2 proteins and uses thereof
7414032	Vaccine comprising a polynucleotide encoding an antigen recognized by a CD4.sup.+ helper T-cell and a polynucleotide encoding a tumor specific or associated antigen recognized by a CD8.sup.+ CTL
7414123	Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies
7415358	Molecular toxicology modeling
7416727	Polypeptide variants with altered effector function
7416872	Taxoid oxygenases and their uses
7416881	Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
7417042	Compounds for enzyme inhibition
7417062	Substituted arylamides
7417128	7C10 and 16C10 CD80-specific antibodies
7413866	Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
7413864	Treating cancer using a telomerase vaccine
7413759	Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
7408039	Kits for treatment of hematologic disorders
7410637	Transgenic algae for delivering antigens to an animal
7410758	Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
7410767	HLA-E binding
7410773	Method of preparing an undifferentiated cell
7410779	Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
7410950	Peptides of CaV2.2 that inhibit pain
7410975	Small molecule toll-like receptor (TLR) antagonists
7411057	Nucleic acids encoding human monoclonal antibodies to CTLA-4
7413537	Directed evolution of disulfide-bonded micro-proteins
7418292	Device and method for attenuating an immune response

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.